» Articles » PMID: 26113648

High Anabolic Potential of Essential Amino Acid Mixtures in Advanced Nonsmall Cell Lung Cancer

Overview
Journal Ann Oncol
Publisher Elsevier
Specialty Oncology
Date 2015 Jun 27
PMID 26113648
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Conventional nutritional supplements are not or only partly successful in inducing protein accretion in advanced cancer, suggesting an attenuated anabolic response. To prevent muscle wasting and its deleterious consequences, generating an anabolic response is crucial. Dietary essential amino acids (EAA) have anabolic properties in other wasting diseases; however, data in advanced cancer are lacking.

Patients And Methods: In 13 patients with advanced nonsmall-cell lung cancer (NSCLC) (stage III and IV) and 11 healthy age-matched subjects, we measured protein synthesis and breakdown of the whole body, and net protein anabolism (difference between protein synthesis and breakdown) after intake of 14 g of free EAA with high leucine levels (EAA/leucine) versus a balanced amino acid mixture containing both EAA and non-EAA as present in whey protein, according to a randomized, double-blind, crossover design.

Results: Protein synthesis and net protein anabolism were higher after intake of the EAA/leucine than the balanced amino acid mixture (P < 0.001), independent of presence of cancer. A highly significant linear relationship between net protein anabolism and the amount of EAA available in the systemic circulation (R(2): 0.85, P < 0.001) was found in both groups. The presence of muscle or recent weight loss, systemic inflammatory response, or length of survival did not influence this relationship. High leucine levels in the EAA/leucine mixture was of no anabolic benefit.

Conclusions: There is no anabolic resistance or attenuated anabolic potential to intake of 14 g of EAA/leucine or balanced amino acid mixture in advanced (mainly stage III) NSCLC. The high anabolic potential of dietary EAA in cancer patients is independent of their nutritional status, systemic inflammatory response or disease trajectory, suggesting a key role of EAA in new nutritional approaches to prevent muscle loss, thereby improving outcome of patients with advanced cancer.

Clinicaltrailsgov: NCT01172314.

Citing Articles

Connection between nutrition and oncology in dogs and cats: perspectives, evidence, and implications-a comprehensive review.

Amaral A, Finardi G, Marchi P, de Oliveira N, Principe L, Teixeira N Front Vet Sci. 2025; 11:1490290.

PMID: 40046187 PMC: 11881598. DOI: 10.3389/fvets.2024.1490290.


Consideration of the role of protein quality in determining dietary protein recommendations.

Wolfe R, Church D, Ferrando A, Moughan P Front Nutr. 2024; 11:1389664.

PMID: 39606577 PMC: 11598328. DOI: 10.3389/fnut.2024.1389664.


International Society of Sports Nutrition Position Stand: Effects of essential amino acid supplementation on exercise and performance.

Ferrando A, Wolfe R, Hirsch K, Church D, Kviatkovsky S, Roberts M J Int Soc Sports Nutr. 2023; 20(1):2263409.

PMID: 37800468 PMC: 10561576. DOI: 10.1080/15502783.2023.2263409.


Gallic acid in theabrownin suppresses cell proliferation and migration in non‑small cell lung carcinoma via autophagy inhibition.

Tian X, Xu J, Ye Y, Xiao X, Yan L, Yu S Oncol Lett. 2023; 26(1):294.

PMID: 37274480 PMC: 10236267. DOI: 10.3892/ol.2023.13880.


Cancer-associated cachexia - understanding the tumour macroenvironment and microenvironment to improve management.

Argiles J, Lopez-Soriano F, Stemmler B, Busquets S Nat Rev Clin Oncol. 2023; 20(4):250-264.

PMID: 36806788 DOI: 10.1038/s41571-023-00734-5.


References
1.
Abumrad N, Rabin D, Diamond M, LACY W . Use of a heated superficial hand vein as an alternative site for the measurement of amino acid concentrations and for the study of glucose and alanine kinetics in man. Metabolism. 1981; 30(9):936-40. DOI: 10.1016/0026-0495(81)90074-3. View

2.
Winter A, MacAdams J, Chevalier S . Normal protein anabolic response to hyperaminoacidemia in insulin-resistant patients with lung cancer cachexia. Clin Nutr. 2012; 31(5):765-73. DOI: 10.1016/j.clnu.2012.05.003. View

3.
Baracos V, Reiman T, Mourtzakis M, Gioulbasanis I, Antoun S . Body composition in patients with non-small cell lung cancer: a contemporary view of cancer cachexia with the use of computed tomography image analysis. Am J Clin Nutr. 2010; 91(4):1133S-1137S. DOI: 10.3945/ajcn.2010.28608C. View

4.
Prado C, Sawyer M, Ghosh S, Lieffers J, Esfandiari N, Antoun S . Central tenet of cancer cachexia therapy: do patients with advanced cancer have exploitable anabolic potential?. Am J Clin Nutr. 2013; 98(4):1012-9. DOI: 10.3945/ajcn.113.060228. View

5.
Dillon E, Volpi E, Wolfe R, Sinha S, Sanford A, Arrastia C . Amino acid metabolism and inflammatory burden in ovarian cancer patients undergoing intense oncological therapy. Clin Nutr. 2007; 26(6):736-43. PMC: 2190298. DOI: 10.1016/j.clnu.2007.07.004. View